Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 18,880 NVAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | NOVAVAX INC (NVAX) | Exercise/Conversion | 18,880 | n/a |
| Jun 18, 2026 | ARDELYX, INC. (ARDX) | Grant/Award | 20,282 | n/a |
| Feb 24, 2026 | ARDELYX, INC. (ARDX) | Purchase | 333,333 | $1.95M |
| Jan 6, 2026 | Mersana Therapeutics, Inc. (MRSN) | Tender of Shares | 23,546 | n/a |
| Jun 24, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 28,326 | $181.9K |
| Jun 24, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 31,163 | n/a |
| Jun 19, 2025 | ARDELYX, INC. (ARDX) | Purchase | 200,000 | $725.9K |
| Jun 14, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 10,420 | n/a |
| Jun 13, 2025 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 61,500 | n/a |
| Jun 12, 2025 | ARDELYX, INC. (ARDX) | Purchase | 200,000 | $737.3K |